DAYS ALIVE AND OUTSIDE OF HOSPITAL IS GREATER AMONG PATIENTS WITH TRANSTHYRETIN CARDIAC AMYLOIDOSIS COMPARED TO LIGHT CHAIN CARDIAC AMYLOIDOSIS AFTER INITIAL HOSPITALIZATION

被引：0
|
作者：
Rubin, Jonah [1 ]
Teruya, Sergio [1 ]
Helmke, Stephen [1 ]
Alvarez, Julissa [1 ]
Maurer, Mathew [1 ]
机构：
[1] Columbia Univ, Med Ctr, New York, NY USA
来源：
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY | 2018年 / 71卷 / 11期
关键词：
D O I：
10.1016/S0735-1097(18)31466-9
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
A925
引用
收藏
页码：925 / 925
页数：1
相关论文
共 50 条
  • [31] MORE IMPAIRED DIASTOLIC FUNCTION OF LIGHT CHAIN AMYLOIDOSIS CONTRIBUTE TO POOR PROGNOSIS COMPARED WITH TRANSTHYRETIN AMYLOIDOSIS: RESULT FROM LONGITUDINAL STUDY OF BIOPSY -PROVEN CARDIAC AMYLOIDOSIS
    Sakamoto, Mari
    Funada, Akira
    Amaki, Makoto
    Ohara, Takahiro
    Hasegawa, Takuya
    Sugano, Yasuo
    Kanzaki, Hideaki
    Kitakaze, Masafumi
    Anzai, Toshihisa
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2015, 65 (10) : A935 - A935
  • [32] Sex-related differences in clinical presentation and all-cause mortality in patients with cardiac transthyretin amyloidosis and light chain amyloidosis
    Zampieri, Mattia
    Argiro, Alessia
    Allinovi, Marco
    Tassetti, Luigi
    Zocchi, Chiara
    Gabriele, Martina
    Andrei, Valentina
    Fumagalli, Carlo
    Di Mario, Carlo
    Tomberli, Alessia
    Olivotto, Iacopo
    Perfetto, Federico
    Cappelli, Francesco
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2022, 351 : 71 - 77
  • [33] More impaired diastolic function of light chain amyloidosis contribute to poor prognosis compared with transthyretin amyloidosis: result from longitudinal study of biopsy-proven cardiac amyloidosis
    Sakamoto, M.
    Funada, A.
    Amaki, A.
    Ohara, T.
    Sugano, Y.
    Hasegawa, T.
    Kanzaki, H.
    Matsuyama, T.
    Ueda, H.
    Anzai, T.
    EUROPEAN HEART JOURNAL, 2014, 35 : 1088 - 1088
  • [34] Arrest of progression of cardiac amyloidosis after chemotherapy predicts favorable outcome in patients with light-chain amyloidosis
    Koyama, J.
    Minamisawa, M.
    Kuwahara, K.
    EUROPEAN HEART JOURNAL, 2020, 41 : 31 - 31
  • [35] Prevalence of transthyretin and immunoglobulin light chain cardiac amyloidosis in patients undergoing transcatheter aortic valve replacement
    Nitsche, Christian
    Kammerlander, Andreas
    Koschutnik, Matthias
    Aschauer, Stefan
    Schneider, Matthias
    Goliasch, Georg
    Poschner, Thomas
    Stiftinger, Julian
    Binder, Christina
    Duca, Franz
    Anvari-Pirsch, Anahit
    Andreas, Martin
    Agis, Hermine
    Hacker, Marcus
    Bonderman, Diana
    Hengstenberg, Christian
    Mascherbauer, Julia
    WIENER KLINISCHE WOCHENSCHRIFT, 2019, 131 : 376 - 376
  • [36] Prevalence of transthyretin and immunoglobulin light chain cardiac amyloidosis in patients undergoing transcatheter aortic valve replacement
    Nitsche, Christian
    Aschauer, Stefan
    Kammerlander, Andreas
    Schneider, Matthias
    Poschner, Thomas
    Duca, Franz
    Binder, Christina
    Stiftinger, Julian
    Ozturk, Begum
    Andreas, Martin
    Beitzke, Dietrich
    Loewe, Christian
    Hacker, Marcus
    Agis, Hermine
    Kain, Renate
    Lang, Irene
    Hengstenberg, Christian
    Bonderman, Diana
    Mascherbauer, Julia
    WIENER KLINISCHE WOCHENSCHRIFT, 2018, 130 : 270 - 270
  • [37] Hepatocyte growth factor has prognostic utility in light chain and transthyretin cardiac amyloidosis
    Zhang, K. W.
    Kraja, A.
    Miao, J.
    Tomasek, K.
    Su, Y. R.
    Lenihan, D. J.
    EUROPEAN HEART JOURNAL, 2019, 40 : 652 - 652
  • [38] Light chain and transthyretin cardiac amyloidosis: Clinical characteristics, natural history and prognostic factors
    Barge-Caballero, Gonzalo
    Vazquez-Garcia, Raquel
    Barge-Caballero, Eduardo
    Couto-Mallon, David
    Paniagua-Martin, Maria J.
    Barriales-Villa, Roberto
    Pinon-Esteban, Pablo
    Bouzas-Mosquera, Alberto
    Pombo-Otero, Jorge
    Deben-Ariznavarreta, Guillermo
    Vazquez-Rodriguez, Jose M.
    Crespo-Leiro, Maria G.
    MEDICINA CLINICA, 2021, 156 (08): : 369 - 378
  • [39] Prevalence and prognostic significance of restriction versus systolic dysfunction in patients with transthyretin and light chain cardiac amyloidosis
    Zampieri, M.
    Biagioni, G.
    Del Franco, A.
    Canepa, M.
    Porcari, A.
    Merlo, M.
    Tini, G.
    Musumeci, B.
    Longhi, S.
    Biagini, E.
    Argiro', A.
    Fumagalli, C.
    Olivotto, I
    Perfetto, F.
    Cappelli, F.
    EUROPEAN HEART JOURNAL, 2024, 45
  • [40] Plasma Hepatocyte Growth Factor for Diagnosis and Prognosis in Light Chain and Transthyretin Cardiac Amyloidosis
    Zhang, Kathleen W.
    Miao, Jennifer
    Mitchell, Joshua D.
    Alvarez-Cardona, Jose
    Tomasek, Kelsey
    Su, Yan Ru
    Gordon, Mary
    Cornell, R. Frank
    Lenihan, Daniel J.
    JACC: CARDIOONCOLOGY, 2020, 2 (01): : 56 - 66
12345